Search Results - "Meinhold, I"

Refine Results
  1. 1

    The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer by Zeppernick, F., Meinhold-Heerlein, I.

    Published in Archives of gynecology and obstetrics (01-11-2014)
    “…Introduction Recent molecular research has revolutionized the understanding of ovarian cancer. It is now non-controversial that the term ovarian cancer…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The heterogeneity of ovarian cancer by Meinhold-Heerlein, I., Hauptmann, S.

    Published in Archives of gynecology and obstetrics (01-02-2014)
    “…Ovarian cancer carries the worst prognosis of all gynecological malignancies. This is mainly due to its resistance against commonly used cytostatic drugs as…”
    Get full text
    Journal Article
  4. 4

    Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency by von Kaisenberg, C.S., Prols, F., Nicolaides, K.H., Maass, N., Meinhold‐Heerlein, I., Brand‐Saberi, B.

    Published in Human reproduction (Oxford) (01-12-2003)
    “…BACKGROUND: First trimester increased fetal nuchal translucency is associated with fetal aneuploidies. One of the mechanisms of pathophysiology could be an…”
    Get full text
    Journal Article
  5. 5

    Induction of Human β-defensins and Psoriasin in Vulvovaginal Human Papillomavirus-Associated Lesions by Erhart, W., Alkasi, Ö., Brunke, G., Wegener, F., Maass, N., Arnold, N., Arlt, A., Meinhold-Heerlein, I.

    Published in The Journal of infectious diseases (01-08-2011)
    “…Background. Infections with a low-risk type of human papillomavirus (HPV) may lead to genital warts. HPV targets the basal cell layer of epithelial cells. The…”
    Get full text
    Journal Article
  6. 6

    Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal Cancer by Meinhold-Heerlein, I, Fotopoulou, C, Harter, P, Kurzeder, C, Mustea, A, Wimberger, P, Hauptmann, S, Sehouli, J

    Published in Geburtshilfe und Frauenheilkunde (01-10-2015)
    “…More than 25 years after the last revision, in 2012 the FIGO Oncology Committee began revising the FIGO classification for staging ovarian, Fallopian tube and…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls by von Kaisenberg, C.S., Wilting, J., Dörk, T., Nicolaides, K.H., Meinhold-Heerlein, I., Hillemanns, P., Brand-Saberi, B.

    Published in Molecular human reproduction (01-10-2010)
    “…Fetuses with Turner's syndrome or trisomies 21, 18 and 13 show excess of skin, which can be visualized by ultrasonography as increased nuchal translucency at…”
    Get full text
    Journal Article
  10. 10

    Borderline-Tumoren des Ovars by Meinhold-Heerlein, I.

    Published in Gynäkologe (Berlin) (01-12-2014)
    “…Zusammenfassung Borderline-Tumoren des Ovars („tumors of low malignant potential“, LMP-Tumoren) stehen klinisch und morphologisch zwischen den benignen Tumoren…”
    Get full text
    Journal Article
  11. 11

    Heterogeneous Expression of Serine Protease Inhibitor Maspin in Ovarian Cancer by BAUERSCHLAG, D. O, HABERMANN, M, SCHEM, C, WEIMER, J, MEINHOLD-HEERLEIN, I, HILPERT, F, WEIGEL, M, BAUER, M, MUNDHENKE, C, JONAT, W, MAASS, N

    Published in Anticancer research (01-07-2010)
    “…Ovarian cancer (OC) is a disease with poor prognosis, and molecular markers are needed to improve understanding of disease progression and resultant treatment…”
    Get full text
    Journal Article
  12. 12

    Zervixkarzinom – Vorsorge, Diagnostik und Therapie by Farrokh, A., Maass-Poppenhusen, K., Meinhold-Heerlein, I., Maass, N.

    Published in Gynäkologe (Berlin) (01-06-2015)
    “…Zusammenfassung Hintergrund In Deutschland gehört das Zervixkarzinom seit Einführung der Früherkennung in 1970er-Jahren zu den selteneren Karzinomen. Weltweit…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Laparoskopie in der gynäkologischen Onkologie by Meinhold-Heerlein, I., Papathemelis, T., Wölfler, M., Maass, N.

    Published in Gynäkologe (Berlin) (01-03-2014)
    “…Zusammenfassung Hintergrund Gynäkologische Malignome werden zunehmend laparoskopisch operiert. Ziel der Arbeit Der vorliegende Beitrag gibt Antworten zu…”
    Get full text
    Journal Article
  16. 16

    Operative Therapie der Endometriose: radikal und schonend zugleich by Alkatout, I., Meinhold-Heerlein, I., von Leffern, I., Maass, N., Mettler, L.

    Published in Gynäkologe (Berlin) (01-03-2015)
    “…Zusammenfassung Hintergrund Endometriose ist die zweithäufigste benigne Erkrankung des weiblichen Genitale nach der Leiomyomatose. Ziel Schwerpunkte dieser…”
    Get full text
    Journal Article
  17. 17

    Prognostische und prädiktive Marker des Ovarialkarzinoms by Meinhold-Heerlein, I., Bräutigam, K., Pecks, U., Maass, N., Bauerschlag, D.O.

    Published in Gynäkologe (Berlin) (01-06-2013)
    “…Zusammenfassung Bedingt durch die häufige Resistenz gegen platinhaltige Chemotherapeutika und das Fehlen einer geeigneten Methode zur Früherkennung hat das…”
    Get full text
    Journal Article
  18. 18

    The value of laparoscopic surgery to stage gynecological cancers: present and future by Mettler, L, Meinhold-Heerlein, I

    Published in Minerva ginecologica (01-08-2009)
    “…The laparoscopic management of gynecologic cancers has been discussed controversely since decades. Much progress has been achieved technically enabling an…”
    Get more information
    Journal Article
  19. 19

    Hysterektomie: interventionelle Alternativen by Söhngen, L., Meinhold-Heerlein, I., Wölfler, M.M., Maass, N.

    Published in Gynäkologe (Berlin) (01-08-2012)
    “…Zusammenfassung Ist eine Gebärmutterentfernung aus medizinischen Gründen indiziert oder besteht der Wunsch nach sicherer Beschwerdefreiheit, werden zur…”
    Get full text
    Journal Article
  20. 20